
Revelation Biosciences (REVB) P/E Ratio
P/E Ratio as of Jun 30, 2025: -0.01
Average-0.0100
Median-0.0100
Minimum-0.0100
Maximum-0.0100
-0.01
Past Month0.00 (0.00%)
The P/E ratio for Revelation Biosciences (REVB) is -0.01 as of Jun 30, 2025. This represents a decrease of -75.00% compared to its 12-month average P/E ratio of -0.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Revelation Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Revelation Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Revelation Biosciences to industry peers.
Revelation Biosciences P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Revelation Biosciences’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Revelation Biosciences to industry peers.
Revelation Biosciences (REVB) P/E Ratio Insights
See Revelation Biosciences’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Revelation Biosciences (REVB)
Order type
Buy in
Order amount
Est. shares
0 shares
Revelation Biosciences (REVB) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $0.823 | -0.01 |
May 1, 2025 | $3.0176 | -0.02 |
Apr 1, 2025 | $2.60 | -0.02 |
Mar 3, 2025 | $3.49 | -0.01 |
Feb 3, 2025 | $3.99 | -0.01 |
Jan 2, 2025 | $10.512 | -0.08 |
Revelation Biosciences (REVB) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.01 | -80.00% |
2024 | -0.05 | -95.28% |
2023 | -1.06 | +341.67% |
2022 | -0.24 | -100.64% |
2021 | 37.56 | — |
FAQs About Revelation Biosciences (REVB) P/E ratio
The latest P/E ratio of Revelation Biosciences (REVB) is -0.01, as of Jun 30, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Revelation Biosciences’s last 12-month average P/E ratio is -0.04, compared to its current P/E ratio of -0.01. This reflects a decrease of -75.00%.
Revelation Biosciences’s current P/E ratio of -0.01 is lower than its last 12-month average P/E of -0.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Revelation Biosciences’s average P/E ratio over the last 3 years is -0.29. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Revelation Biosciences’s average P/E ratio over the last 5 years is 3.45. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.